CAN A MODEL EXPLAINER AGENT ACCELERATE MANUFACTURER RESPONSES TO HEALTH TECHNOLOGY ASSESSMENT CLARIFICATION QUESTIONS?
Author(s)
Tushar Srivastava, MSc, Hanan Irfan, MSc, Thaison Tong, MSc, Shilpi Swami, MSc.
ConnectHEOR, London, United Kingdom.
ConnectHEOR, London, United Kingdom.
OBJECTIVES: After a model submission, health technology assessment (HTA) bodies issue clarification questions that manufacturers must answer within tight windows, requiring rapid, accurate explanation of model logic. We evaluated whether a model explainer agent, a conversational AI agent that explains an economic model in natural language, could accelerate clarification-response drafting without compromising accuracy or methodological ownership.
METHODS: The agent ingested an Excel cost-effectiveness model ofrare disease: a Markov cohort model with 5 health states, quarterly cycles, a lifetime horizon and a payer perspective (36 worksheets, ~150,000 cells). It was parsed into a structured, queryable representation, with documentation indexed via retrieval-augmented generation (RAG). A panel of 30 technical clarification questions related to model, simulated from submissions to NICE and Canada's Drug Agency (CDA-AMC), spanned structure, parameter traceability, costs, utilities, discounting, extrapolation and scenario requests. For each, it located the worksheet, cell range and driving formula, explained the rationale and drafted a reviewer-ready response. Senior modeler adjudicated outputs against a manual baseline. The agent explained but never modified the model and allow modeler to own the output and query further for clarifications.
RESULTS: The agent correctly localised the relevant component for 30 of 30 questions (100%) on first pass, with accurate performance on logic embedded in even VBA-automated probabilistic analysis. Median time to a first draft fell from about 2 hours to 8 minutes per question and the full package from 2-3 weeks to about 1.5 days. Every adjudicated reference and assumption traced to a real cell or source passage; none were fabricated. Failure modes included residual verbosity, two scenario-tab mislabeling, and an inability to adjudicate methodological defensibility, which stayed a senior-economist decision.
CONCLUSIONS: A governed, human-in-the-loop model explainer agent accelerated clarification-response drafting across two HTA jurisdictions while preserving traceability and expert ownership, functioning as decision support rather than a replacement for methodological judgement.
METHODS: The agent ingested an Excel cost-effectiveness model ofrare disease: a Markov cohort model with 5 health states, quarterly cycles, a lifetime horizon and a payer perspective (36 worksheets, ~150,000 cells). It was parsed into a structured, queryable representation, with documentation indexed via retrieval-augmented generation (RAG). A panel of 30 technical clarification questions related to model, simulated from submissions to NICE and Canada's Drug Agency (CDA-AMC), spanned structure, parameter traceability, costs, utilities, discounting, extrapolation and scenario requests. For each, it located the worksheet, cell range and driving formula, explained the rationale and drafted a reviewer-ready response. Senior modeler adjudicated outputs against a manual baseline. The agent explained but never modified the model and allow modeler to own the output and query further for clarifications.
RESULTS: The agent correctly localised the relevant component for 30 of 30 questions (100%) on first pass, with accurate performance on logic embedded in even VBA-automated probabilistic analysis. Median time to a first draft fell from about 2 hours to 8 minutes per question and the full package from 2-3 weeks to about 1.5 days. Every adjudicated reference and assumption traced to a real cell or source passage; none were fabricated. Failure modes included residual verbosity, two scenario-tab mislabeling, and an inability to adjudicate methodological defensibility, which stayed a senior-economist decision.
CONCLUSIONS: A governed, human-in-the-loop model explainer agent accelerated clarification-response drafting across two HTA jurisdictions while preserving traceability and expert ownership, functioning as decision support rather than a replacement for methodological judgement.
Conference/Value in Health Info
2026-11, ISPOR Europe 2026, Vienna, Austria
Value in Health, Volume 29, Issue 12S
Code
MSR297
Topic
Methodological & Statistical Research
Topic Subcategory
Artificial Intelligence, Machine Learning, Predictive Analytics
Disease
No Additional Disease & Conditions/Specialized Treatment Areas